WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Neurolucida
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raber, J.
Right arrow Articles by Mucke, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raber, J.
Right arrow Articles by Mucke, L.

 Previous Article  |  Next Article 

The Journal of Neuroscience, March 1, 2000, 20(5):2064-2071

Hypothalamic-Pituitary-Adrenal Dysfunction in Apoeminus /minus Mice: Possible Role in Behavioral and Metabolic Alterations

Jacob Raber1, 2, Susan F. Akana3, Seema Bhatnagar3, Mary F. Dallman3, Derek Wong1, and Lennart Mucke1, 2

1 Gladstone Institute of Neurological Disease and Departments of 2 Neurology and 3 Physiology, University of California, San Francisco, California 94141-9100

Several neurological diseases are frequently accompanied by dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis regulates the secretion of glucocorticoids (GCs), which play important roles in diverse brain functions, including cognition, emotion, and feeding. Under physiological conditions, GCs are adaptive and beneficial; however, prolonged elevations in GC levels may contribute to neurodegeneration and brain dysfunction. In the current study, we demonstrate that apolipoprotein E (apoE) deficiency results in age-dependent dysregulation of the HPA axis through a mechanism affecting primarily the adrenal gland. Apoe-/- mice, which develop neurodegenerative alterations as they age, had an age-dependent increase in basal adrenal corticosterone content and abnormally increased plasma corticosterone levels after restraint stress, whereas their plasma and pituitary adrenocorticotropin levels were either unchanged or lower than those in controls. HPA axis dysregulation was associated with behavioral and metabolic alterations. When anxiety levels were assessed in the elevated plus maze, Apoe-/- mice showed more anxiety than wild-type controls. Apoe-/- mice also showed reduced activity in the open field. Finally, Apoe-/- mice showed age-dependent increases in food and water intake, stomach and body weights, and decreases in brown and white adipose tissues. These results support a key role for apoE in the tonic inhibition of steroidogenesis and HPA axis activity and have important implications for the behavioral analysis of Apoe-/- mice.

Key words: apoE; pituitary; adrenal gland; ACTH; corticosterone; HPA axis; anxiety; open field activity; metabolism


Copyright © 2000 Society for Neuroscience  0270-6474/00/2052064-08$05.00/0


This article has been cited by other articles:


Home page
HypertensionHome page
M. M. Elahi, F. R. Cagampang, F. W. Anthony, N. Curzen, S. K. Ohri, and M. A. Hanson
Statin Treatment in Hypercholesterolemic Pregnant Mice Reduces Cardiovascular Risk Factors in Their Offspring
Hypertension, April 1, 2008; 51(4): 939 - 944.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Esposito, J. Raber, L. Kekonius, F. Yan, G.-Q. Yu, N. Bien-Ly, J. Puolivali, K. Scearce-Levie, E. Masliah, and L. Mucke
Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.
J. Neurosci., May 10, 2006; 26(19): 5167 - 5179.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Chin, J. J. Palop, J. Puolivali, C. Massaro, N. Bien-Ly, H. Gerstein, K. Scearce-Levie, E. Masliah, and L. Mucke
Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease
J. Neurosci., October 19, 2005; 25(42): 9694 - 9703.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
R. J. Caselli, E. M. Reiman, J. G. Hentz, D. Osborne, and G. E. Alexander
A Distinctive Interaction Between Chronic Anxiety and Problem Solving in Asymptomatic APOE e4 Homozygotes
J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 320 - 329.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. M. Harris, W. J. Brecht, Q. Xu, I. Tesseur, L. Kekonius, T. Wyss-Coray, J. D. Fish, E. Masliah, P. C. Hopkins, K. Scearce-Levie, et al.
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice
PNAS, September 16, 2003; 100(19): 10966 - 10971.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. E. Thorngate, P. A. Strockbine, S. K. Erickson, and D. L. Williams
Altered adrenal gland cholesterol metabolism in the apoE-deficient mouse
J. Lipid Res., November 1, 2002; 43(11): 1920 - 1926.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Raber, G. Bongers, A. LeFevour, M. Buttini, and L. Mucke
Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits
J. Neurosci., June 15, 2002; 22(12): 5204 - 5209.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. R. Peskind, C. W. Wilkinson, E. C. Petrie, G. D. Schellenberg, and M. A. Raskind
Increased CSF cortisol in AD is a function of APOE genotype
Neurology, April 24, 2001; 56(8): 1094 - 1098.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-